Your image

Winfried W. Häuser

Details
Name
Winfried W.
Last name
Häuser
Degree
Prof. Dr.
Language
German, English
Biography

Name

Winfried W. Häuser

Adress

Department of Internal Medicine I/Interdisciplinary center for pain therapy, Academic Hospital Saarbruecken, Winterberg 1, D-66119 Saarbruecken, Germany

Nationality

German

Date of Birth

18.09.1957

Place of Birth

Homburg/Saar, Germany

 

Education, Training

1963 - 1976

School and High School

1976 - 1982

Medical and Psychological Studies, University of Saarbrücken

1982 – 1988

Resident, Department of Cardiology/Intensive Care (Prof. Dr. med. Hennersdorf), Department of Nephrology/Hemodialysis (Dr. med. Traut) and Department of Gastroenterology, Hepatology and Diabetology, SHG – Kliniken Völklingen, Germany

1989 – 1997

Senior Consultant Department of Gastroenterology, Hepatology and Diabetology, SHG – Kliniken Völklingen, Germany

 

Position Held

1998 -

Senior Consultant Gastroenterology / Hepatology, Department of Internal Medicine I and Head of the subdepartment Psychosomatic Medicine, Academic Hospital Saarbruecken, Germany

2002 -

Head of the Interdisciplinary Center for Pain Therapy, Academic Hospital Saarbruecken, Germany

 

Degrees

1984

Doctorate (summa cum laude)

“Paradigm change in Psychosomatic medicine – consequences of systems theory within an empirical study of patients with Crohn’s disease and the theory of chronic inflammatory bowel diseases ”

University of Saarbrücken, Germany

 

 

2010

Associate Professor

 “Chronic widespread pain – classification, diagnosis and evidence-based management ”

Technical University München, Munich, Germany

 

2016                        Adjunct Professor, Psychosomatic Medicine, Technical University München,             

                                Germany

Publications
Publications

 

 

Kategorie
IF
Rang ISI Jahr Publika-tion

Neufeld T, Pfuhlmann K, Stock-Schröer B, Kairey L, Bauer N, Häuser W, Langhorst J. Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey. Z Gastroenterol. 2021 Jun 22. English. doi: 10.1055/a-1400-2768

Gastroenterology

1.338

 

Tölle T, Fitzcharles MA, Häuser W. Is opioid therapy for chronic non-cancer pain associated with a greater risk of all-cause mortality compared to non-opioid analgesics? A systematic review of propensity score matched observational studies. Eur J Pain 2021 Feb 3.

Anesthesiology and Pain Medicine

3.930

10/31

Schmalbach B, Häuser W, Brähler E, Henningsen P, Wolfe F. Fibromyalgia revisited: do latent class analyses of symptom profiles in the general population confirm 2016 fibromyalgia diagnostic criteria? Clin Exp Rheumatol 2021; 39 Suppl 130:128-136

Rheumatology

4.406

 

Fitzcharles MA, Rampakakis E, Sampalis J, Shir Y, Cohen M, Starr M, Häuser W. Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study. Clin Exp Rheumatol 2021; 39 Suppl 130:115-119.

Rheumatology

4.406

 

Häuser W, Buchser E, Finn D, Dom G, Fors E, Heiskanen T, Jarlbaek L, Knaggs RD, Kosek E, Krcevski-Škvarč N, Pakkonen K, Perrot S, Trouvin AP, Morlion B. Is Europe also facing an opioid crisis?-A survey of European Pain Federation chapters. Eur J Pain 2021; 25:1760–1769.

Anesthesiology and Pain Medicine

3.930

10/31

Wager J, Ruhe AK, Stahlschmidt L, Leitsch K, Claus BB, Häuser W, Brähler E, Dinkel A, Kocalevent R, Zernikow B. Long-term outcomes of children with severe chronic pain: Comparison of former patients with a community sample. Eur J Pain 2021; 25:1329-1341

Anesthesiology and Pain Medicine

3.930

10/31

Häuser W, Brähler E, Ablin J, Wolfe F. 2016 modified American College of Rheumatology fibromyalgia criteria, ACTTION-APS Pain Taxonomy criteria and the prevalence of fibromyalgia. Arthritis Care Res (Hoboken) 2021;73:617-625

Rheumatology

4.530

 

Krčevski Škvarč N, Morlion B, Vowles KE, Bannister K, Buchsner E, Casale R, Chenot JF, Chumbley G, Drewes AM, Dom G, Jutila L, O'Brien T, Pogatzki-Zahn E, Rakusa M, Suarez-Serrano C, Tölle T, Häuser W. European clinical practice recommendations on opioids for chronic noncancer pain - Part 2: Special situations. Eur J Pain 2021;25:969-985.

Anesthesiology and Pain Medicine

3.930

10/31

Häuser W, Morlion B, Vowles KE, Bannister K, Buchser E, Casale R, Chenot JF, Chumbley G, Drewes AM, Dom G, Jutila L, O'Brien T, Pogatzki-Zahn E, Rakusa M, Suarez-Serrano C, Tölle T, Krčevski Škvarč N. European* clinical practice recommendations on opioids for chronic noncancer pain - Part 1: Role of opioids in the management of chronic noncancer pain. Eur J Pain 2021;25:949-968.

Anesthesiology and Pain Medicine

3.930

10/31

Häuser W, Schubert T, Vogelmann T, Maier C, Fitzcharles MA, Tölle T. All-cause mortality in patients with long-term opioid therapy compared with non-opioid analgesics for chronic non-cancer pain: a database study. BMC Med 2020;18:162.

General and Internal Medicine

8.285

10/155

Fitzcharles MA, Rampakakis E, Sampalis J, Shir Y, Cohen M, Starr M, Häuser W. Medical Cannabis Use by Rheumatology Patients Following Recreational Legalization: A Prospective Observational Study of 1000 Patients in Canada. ACR Open Rheumatol 2020 Apr 30.

Rheumatology

-

 

Häuser W, Constanze-Hausteiner-Wiehle, Henningsen P, Brähler E, Schmalbach B,

Wolfe F. Prevalence and overlap of somatic symptom disorder, bodily distress syndrome and fibromyalgia syndrome in the German general population: A cross sectional study. J Psychosom Res 2020;133:110111.

Psychiatry

2.860

 

Salaffi F, Di Carlo M, Farah S, Atzeni F, Buskila D, Ablin JN, Häuser W, Sarzi-Puttini P. Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status. Rheumatology (Oxford). 2020;59:3042-304

Rheumatology

5.149

 

Wolfe F, Ablin J, Baker JF, Diab R, Guymer EK, Littlejohn GO, Michaud K, Rasker JJ, Walitt B, Häuser W. All-cause and cause-specific mortality in persons with fibromyalgia and widespread pain: An observational study in 35,248 persons with rheumatoid arthritis, non-inflammatory rheumatic disorders and clinical fibromyalgia. Semin Arthritis Rheum 2020 ;50:1457-1464.

Rheumatology

4.751

 

Petzke F, Klose P, Welsch P, Sommer C, Häuser W. Opioids for chronic low back pain: An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks of double-blind duration. Eur J Pain 2020 ;24:497-517

Anesthesiology and Pain Medicine

3.188

10/31

Welsch P, Petzke F, Klose P, Häuser W. Opioids for chronic osteoarthritis pain: An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks double-blind duration. Eur J Pain 2020;24:685-703.

Anesthesiology and Pain Medicine

3.188

10/31

Schmalbach B, Roenneberg C, Hausteiner-Wiehle C, Henningsen P, Brähler E,

Zenger M, Häuser W. Validation of the German version of the Bodily Distress Syndrome 25 checklist in a representative German population sample. J Psychosom Res 2020 May;132:109991.

Psychiatry

2.860

 

Bialas P, Maier C, Klose P, Häuser W. Efficacy and harms of long-term opioid therapy in chronic non-cancer pain: Systematic review and meta-analysis of open-label extension trials with a study duration ≥26 weeks. Eur J Pain 2020

;24:265-278.

Anesthesiology and Pain Medicine

3.188

10/31

Sommer C, Klose P, Welsch P, Petzke F, Häuser W. Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least four weeks duration. Eur J Pain 2020; 24:3-18

Anesthesiology and Pain Medicine

3.188

10/31

Häuser W, Welsch P, Klose P, Radbruch L, Fitzcharles MA. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain :

A systematic review with meta-analysis of randomised controlled trials. Schmerz.

2019;33:424-436.

Anesthesiology and Pain Medicine

1.267

 

Bialas P, Drescher B, Gottschling S, Juckenhöfel S, Konietzke D, Kuntz W, Kühne-Adler I, Merl-Ripplinger H, Preisegger D, Schneider K, Strauß M, Welsch P,  Häuser W. [Cannabis-based medicines for chronic pain: indications, selection of drugs, effectiveness and safety : Experiences of pain physicians in Saarland]. Schmerz. 2019;33:399-406. Erratum in: Schmerz. 2019 Sep 16;

Anesthesiology and Pain Medicine

1.267

 

Wolfe F, Butler SH, Fitzcharles M, Häuser W, Katz RL, Mease PJ, Rasker JJ, Russell AS, Russell IJ, Walitt B. Revised chronic widespread pain criteria:development from and integration with fibromyalgia criteria. Scand J Pain 2019

Oct 9.

 

 

 

Häuser W, Marschall U, Layer P, Grobe T. The prevalence, comorbidity, management and costs of irritable bowel syndrome—an observational study using routine health insurance data. Dtsch Arztebl Int 2019; 116: 463–70.

Medicine, General and Internal

4.257

18/154

Häuser W, Petzke F. [Evidence of the efficacy and safety of cannabis medicines for chronic pain management : A methodological minefield]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Jul;62(7):836-844.

Öffentliches Gesundheits-wesen, Umwelt- und Arbeitsmedizin

0.901

 

Wolfe F, Schmukler J, Jamal S, Castrejon I, Gibson KA, Srinivasan S, Häuser W, Pincus T. Diagnosis of Fibromyalgia: Disagreement Between Fibromyalgia Criteria and Clinician-Based Fibromyalgia Diagnosis in a University Clinic. Arthritis Care Res (Hoboken) 2019;71:343-351.

Rheumatology

4.149

9/30

Schwarze M, Häuser W, Schmutzer G, Brähler E, Beckmann NA, Schiltenwolf M. Obesity, depression and hip pain. Musculoskeletal Care. 2019 Jan 8.

 

 

 

Häuser W, Brähler E, Schmutzer G, Glaesmer H. The association of adverse childhood experiences and of resilience with chronic noncancer pain in the German adult population - A cross-sectional survey. Eur J Pain 2019; 23:555–564

Anesthesiology and Pain Medicine

3.188

10/31

Wolfe F, Walitt B, Rasker JJ, Häuser W. Primary and Secondary Fibromyalgia Are The Same: The Universality of Polysymptomatic Distress. J Rheumatol 2019; 46:204-212

Rheumatology

3.150

13/30

Bernardy K, Klose P, Welsch P, Häuser W. Efficacy, acceptability and safety of Internet-delivered psychological therapies for fibromyalgia syndrome: A systematic review and meta-analysis of randomized controlled trials. Eur J Pain 2019;23:3-14.

Anesthesiology and Pain Medicine

3.188

10/31

Häuser W, Schubert T, Scherbaum N, Tölle T. [Long-term opioid therapy of non-cancer pain : Prevalence and predictors of hospitalization in the event of possible misuse]. Schmerz 2018 ;32:419-426.

Anesthesiology and Pain Medicine

1.215

26/30

Schüchen RH, Mücke M, Marinova M, Kravchenko D, Häuser W, Radbruch L, Conrad

R. Systematic review and meta-analysis on non-opioid analgesics in palliative medicine. J Cachexia Sarcopenia Muscle 2018;9:1235-1254.

Medicine, General and Internal

9.697

8/155

Hüppe A, Langbrandtner J, Häuser W, Raspe H, Bokemeyer B. Validation of the "German Inflammatory Bowel Disease Activity Index (GIBDI)": An Instrument for Patient-Based Disease Activity Assessment in Crohn's Disease and Ulcerative Colitis. Z Gastroenterol 2018; 56:1267-75

Gastroenterology

1.618

 

Wolfe F, Walitt B, Perrot S, Rasker JJ, Häuser W. Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PLoS One 13:e0203755.

Medicine, General and Internal

2.766

 

Welsch P, Bernardy K, Derry S, Moore RA, Häuser W. Mirtazapine for fibromyalgia in adults. Cochrane Database Syst Rev 2018;8:CD012708.

Medicine, General and Internal

6.124

14/154

Pratesi CP, Häuser W, Uenishi RH, Selleski N, Nakano EY, Gandolfi L, Pratesi R, Zandonadi RP. Quality of Life of Celiac Patients in Brazil: Questionnaire Translation, Cultural Adaptation and Validation. Nutrients 2018;10: pii: E1167.

Nutrition and Diabetics

4.196

21/77

Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Cannabis-based medicines

for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2018;3:CD012182

Medicine, General and Internal

6.124

14/154

Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst Rev 2018;2:CD010292.

Medicine, General and Internal

6.124

14/154

Häuser W, Petzke F, Fitzcharles MA. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews. Eur J Pain 2018;22:455-470.

Anesthesiology and Pain Medicine

3.018

10/31

Krcevski-Skvarc N, Wells C, Häuser W. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain

Federation. Eur J Pain 2018;22:440-454.

Anesthesiology and Pain Medicine

3.018

10/31

Häuser W, Perrot S, Clauw DJ, Fitzcharles MA. Unravelling Fibromyalgia-Steps Toward Individualized Management. J Pain 2018;19:125-134.

Clinical Neurology

4.591

31/194

Bernardy K, Klose P, Welsch P, Häuser W. Efficacy, acceptability and safety of

cognitive behavioural therapies in fibromyalgia syndrome - A systematic review and meta-analysis of randomized controlled trials. Eur J Pain 2018;22:242-260.

Anesthesiology and Pain Medicine

3.018

10/31

Häuser W, Schubert T. Scherbaum N, Tölle T. Guideline-recommended vs high-dose long-term

opioid therapy for chronic noncancer pain is

associated with better health outcomes: data from a representative sample of the German population. Pain 2018;159:85-92

Anesthesiology and Pain Medicine

5.445

3/31

Mücke M, Weier M, Carter C, Copeland J, Degenhardt L, Cuhls H, Radbruch L, Häuser H, Conrad R. Systematic review and meta-analysis of cannabinoids in palliative medicine. J Cachexia, Sarcopenia and Muscle 2018;9:220-34

Medicine, General and Internal

9.697

8/155

Häuser W, Fitzcharles MA, Radbruch L, Petzke F. Cannabinoids in pain management and palliative medicine – an overview of systematic reviews and prospective observational studies. Dtsch Ärztebl Int 2017;114:627-34.

Medicine, General and Internal

4.257

18/154

Häuser W, Petzke F, Kopp I, Nothacker M. [Impact of conflicts of interest on

guideline recommendations : Empirical study within the second update of the

German interdisciplinary S3 guidelines on fibromyalgia syndrome]. Schmerz 2017;31:308-318.

Anesthesiology and Pain Medicine

1.215

26/30

Derry S, Wiffen PJ, Häuser W, Mücke M, Tölle TR, Bell RF, Moore RA. Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults. Cochrane Database Syst Rev 2017 ;3:CD012332.

Medicine, General and Internal

6.103

12/152

Hellou R, Häuser W, Brenner I, Buskila D, Jacob G, Elkayam O, Aloush V, Ablin JN. Self- Reported Childhood Maltreatment and Traumatic Events among Israeli Patients Suffering from Fibromyalgia and Rheumatoid Arthritis. Pain Res Manag 2017;2017:3865249

 

1.685

 

Zech N, Hansen E, Bernardy K, Häuser W. Efficacy, acceptability and safety of

guided imagery/hypnosis in fibromyalgia - A systematic review and meta-analysis

of randomized controlled trials. Eur J Pain 2017;21:217-227

Anesthesiology and Pain Medicine

2.900

9/31

Türp JC, Schmutzer G, Brähler E, Häuser W. Prevalence of self-reported jaw pain in Germany: two cross-sectional surveys of the general German population. Clin Oral Investig 2016;20:1895-1901.

 

2.207

 

Wolfe F, Egloff N, Häuser W. Widespread Pain and Low Widespread Pain Index Scores among Fibromyalgia-positive Cases Assessed with the 2010/2011 Fibromyalgia Criteria. J Rheumatol 2016;43:1743-8

Rheumatology

3.690

12/32

Walitt B, Klose P, Fitzcharles MA, Phillips T, Häuser W. Cannabinoids for fibromyalgia. Cochrane Database Syst Rev 2016;7:CD011694.

Medicine, General and Internal

6.103

12/152

Schilling C, Weidner K, Brähler E, Glaesmer H, Häuser W, Pöhlmann K. Patterns of Childhood Abuse and Neglect in a Representative German Population Sample. PLoS One.  016;11:e0159510.

Medicine, General and Internal

3.057

 

Walitt B, Klose P, Üçeyler N, Phillips T, Häuser W. Antipsychotics for fibromyalgia in adults. Cochrane Database Syst Rev 016;6:CD011804.

Medicine, General and Internal

6.103

12/152

Fitzcharles MA, Ste-Marie PA, Häuser W, Clauw DJ, Jamal S, Karsh J, Landry T, Leclercq S, Mcdougall JJ, Shir Y, Shojania K, Walsh Z. Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials. Arthritis Care Res (Hoboken) 2016;68(5):681-8.

Rheumatology

4.713

5/32

Wolfe F, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell

AS, Jon Russell I, Walitt B. Comparison of Physician-Based and Patient-Based

Criteria for the Diagnosis of Fibromyalgia. Arthritis Care Res (Hoboken) 2016;68(5):652-9.

Rheumatology

4.713

5/32

Häuser W, Hagl M, Schmierer A, Hansen E. Wirksamkeit, Sicherheit und

Anwendungsmöglichkeiten medizinischer

Hypnose. Eine systematische Übersicht von Metaanalysen. Dtsch Arztebl Int 2016; 113: 289–96.

Medicine, General and Internal

4.257

18/154

Marschall U, L'hoest H, Radbruch L, Häuser W. Long-term opioid therapy for chronic non-cancer pain in Germany. Eur J Pain 2016; 20:767-76

Anesthesiology and Pain Medicine

2.900

9/31

Hinz A, Häuser W, Glaesmer H, Brähler E. The relationship between perceived own health state and health assessments of anchoring vignettes. International Journal of Clinical and Health Psychology 2016, 16,128-136

Clinical Psychology

2.850

 

Petzke F, Enax-Krumova EK, Häuser W. Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies. Schmerz  2016 30(1):62-88.

Anesthesiology and Pain Medicine

1.336

26/30

Mücke M, Carter C, Cuhls H, Prüß M, Radbruch L, Häuser W. Cannabinoids in

palliative care : Systematic review and meta-analysis of efficacy, tolerability

and safety. Schmerz 2016;30(1):25-36.

Anesthesiology and Pain Medicine

1.336

26/30

Volz MS, Siegmund B, Häuser W. Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review. Schmerz 2016;30(1):37-46.

Anesthesiology and Pain Medicine

1.336

26/30

Tafelski S, Häuser W, Schäfer M. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting-a systematic review of systematic reviews. Schmerz 2016;30(1):14-24

Anesthesiology and Pain Medicine

1.336

26/30

Fitzcharles MA, Baerwald C, Ablin J, Häuser W. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis) : A

systematic review of randomized controlled trials. Schmerz 2016;30(1):47-61

Anesthesiology and Pain Medicine

1.336

26/30

Krasselt M, Häuser W, Petzke F, Baerwald C. [S3 guidelines on long-term opioid treatment in non-cancer pain : Recommendations for opioid use in clinical rheumatology]. Z Rheumatol. 2015 Nov 13.

 

 

 

Dinkel A, Schneider A, Schmutzer G, Brähler E, Häuser W. Family physician-patient relationship and frequent attendance of primary and specialist  health care: Results from a German population-based cohort study. Patient Educ

Couns. 2016 Feb 16.

 

 

 

Türp JC, Schmutzer G, Brähler E, Häuser W. Prevalence of self-reported jaw pain in Germany: two cross-sectional surveys of the general German population. Clin Oral Investig. 2016; 20:1895–1901

Dentistry, Oral Surgery & Medicine

2.352

18/87

Marschall U, L'hoest H, Radbruch L, Häuser W. Long-term opioid therapy for chronic non-cancer pain in Germany. Eur J Pain 2016; 20:767-76

Anesthesiology and Pain Medicine

3.218

6/29

Hilbert A, Braehler E, Schmidt R, Löwe B, Häuser W, Zenger M. Self-Compassion

as a Resource in the Self-Stigma Process of Overweight and Obese Individuals.

Obes Facts 2015;8(5):293-301.

Endocrinology & Metabolism

2.245

80/128

Häuser W, Schmutzer G, Hilbert A, Brähler E, Henningsen P. Prevalence of Chronic Disabling Non cancer Pain and Associated Demographic and Medical Variables: A Cross-Sectional Survey in the General German Population. Clin J Pain 2015 ;31:886-92

Anesthesiology and Pain Medicine

2.703

8/29

Wolfe F, Walitt BT, Rasker JJ, Katz RS, Häuser W. The Use of Polysymptomatic Distress Categories in the Evaluation of Fibromyalgia (FM) and FM Severity. J Rheumatol  2015; 42;1494-1501

Rheumatology

3.731

9/29

Aksan A, Mercanlıgil SM, Häuser W, Karaismailoğlu E. Validation of the Turkish

version of the Celiac Disease Questionnaire (CDQ). Health Qual Life Outcomes 2015;13:82.

HEALTH CARE SCIENCES & SERVICES

2.120

33/89

Walitt B, Urrútia G, Nishishinya MB, Cantrell SE, Häuser W. Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev 2015;6:CD011735

Medicine, General & Internal

6.103

10/150

Werber A, Marschall U, L’hoest H, Häuser W, Babak M, Schiltenwolf M. Opioid Therapy in the Treatment of Chronic Pain Conditions in Germany. Pain Physician 2015; 18:E323-E331

Clinical Neurology

4.766

24/194

Häuser W, Bialas P, Welsch K, Wolfe F. Construct validity and clinical utility of current research criteria of DSM-5 somatic symptom disorder diagnosis in patients with fibromyalgia syndrome. J Psychosom Res 2015; 78:546-52

Psychiatry

2.839

52/136

Häuser W, Hoffmann EM, Wolfe F, Worthing AB, Stahl N, Rothenberg R, Walitt B.

Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in fibromyalgia syndrome: a comparison of US and German outpatients. Clin Exp Rheumatol 2015;33(1 Suppl 88):86-92

Rheumatology

2.973

15/30

Lauche R, Klose P, Radbruch L, Welsch P, Häuser W. Opioids in chronic

noncancer pain-are opioids different? : A systematic review and meta-analysis of

efficacy, tolerability and safety in randomized head-to-head comparisons of

opioids of at least four week's duration. Schmerz 2015; 29:73-84

Anesthesiology and Pain Medicine

0.894

26/30

Welsch P, Sommer C, Schiltenwolf M, Häuser W. Opioids in chronic noncancer

pain-are opioids superior to nonopioid analgesics? : A systematic review and

meta-analysis of efficacy, tolerability and safety in randomized head-to-head

comparisons of opioids versus nonopioid analgesics of at least four week's

duration. Schmerz 2015; 29:85-95

Anesthesiology and Pain Medicine

0.894

26/30

Schaefert R, Welsch P, Klose P, Sommer C, Petzke F, Häuser W. [Opioids in

chronic osteoarthritis pain : A systematic review and meta-analysis of efficacy,

tolerability and safety in randomized placebo-controlled studies of at least

4 weeks duration.]. Schmerz 2015; 29:47-59

Anesthesiology and Pain Medicine

0.894

26/30

Häuser W, Bernardy K, Maier C. [Long-term opioid therapy in chronic noncancer

pain : A systematic review and meta-analysis of efficacy, tolerability and safety

in open-label extension trials with study duration of at least 26 weeks.Schmerz 2015; 29;96-108

Anesthesiology and Pain Medicine

0.894

26/30

Petzke F, Welsch P, Klose P, Schaefert R, Sommer C, Häuser W. [Opioids in

chronic low back pain : A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration. Schmerz 2015; 29:60-72

Anesthesiology and Pain Medicine

0.894

26/30

Sommer C, Welsch P, Klose P, Schaefert R, Petzke F, Häuser W. Opioids in

chronic neuropathic pain : A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration. Schmerz 2015; 29:35-46

Anesthesiology and Pain Medicine

0.894

26/30

Häuser W, Schmutzer G, Brähler E, Schiltenwolf M, Hilbert A. The Impact of Body Weight and Depression on Low Back Pain in a representative Population Sample. Pain Med 2014;15(8):1316-27

Medicine General & Internal

2.243

39/150

Wolfe F, Michaud K, Busch RE, Katz RS, Rasker JJ, Shahouri SH, Shaver TS, Wang

S, Walitt BT, Häuser W. Polysymptomatic distress in patients with rheumatoid arthritis: understanding disproportionate response and its spectrum. Arthritis Care Res (Hoboken) 2014;66(10):1465-71.

Rheumatology

3.731

9/29

Häuser W, Schmutzer G, Henningsen P, Brähler E. [Chronic pain, pain disease, and satisfaction of patients with pain treatment in Germany: Results of a representative population survey]. Schmerz 2014;28(5):483-92.

Anesthesiology and Pain Medicine

1.504

22/29

Wolfe F, Walitt BT, Katz RS, Häuser W. Social security work disability and its predictors in patients with fibromyalgia. Arthritis Care Res (Hoboken) 2014;66(9):1354-63.

Rheumatology

3.731

9/29

Schaefert R, Klose P, Moser G, Häuser W. Efficacy, tolerability, and safety of hypnosis in adult irritable bowel syndrome: systematic review and meta-analysis. Psychosom Med 2014;76(5):389-98.

Psychiatry

4.084

17/120

Häuser W, Wolfe F, Henningsen P, Schmutzer G, Brähler E, Hinz A. Untying chronic pain: prevalence and societal burden of chronic pain stages in the general population - a cross-sectional survey. BMC Public Health 2014; 13;14(1):352

Public Health, Environmental and Occupational Health

2.321

45/347

Zenger M, Schaefert R, van der Feltz-Cornelis C, Brähler E, Häuser W. Validation of the Patient-Doctor-Relationship Questionnaire (PDRQ-9) in a Representative Cross-Sectional German Population Survey. PLoS One 2014;9(3):e91964

General and multidisciplinary sciences

3.730

4/57

Häuser W, Schmutzer G, Brähler E, Wolfe F.  Patient Health Questionnaire 15 as a generic measure of severity in fibromyalgia syndrome: Surveys with patients of three different settings. J Psychosom Res 2014;76:307-311

 

2.839

 

Hilbert A, Braehler E, Haeuser W, Zenger M. Weight bias internalization, core self-evaluation, and health in overweight and obese persons. Obesity (Silver Spring) 2014;22(1):79-85.

Nutrition&

Dietetics

3.922

12/76

Wolfe F, Wallitt BT,Katz RS, Häuser W. Symptoms, the Nature of Fibromyalgia, and Diagnostic and Statistical Manual 5 (DSM-5) Defined Mental Illness in Patients with Rheumatoid Arthritis and Fibromyalgia. PLOS One 2014; 9: e88740

General and multidisciplinary sciences

3.730

4/57

Lauche R, Häuser W, Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F, Weiss T, Thoma R, Winkelmann A, Langhorst J. Patient-related predictors of treatment satisfaction of patients with fibromyalgia syndrome: results of a cross-sectional survey. Clin Exp Rheumatol 2013;31(6 Suppl

79):34-40.

Rheumatology

2.973

14/29

Uçeyler N, Sommer C, Walitt B, Häuser W. Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev. 2013;10:CD010782.

Medicine, General & Internal

5.935

10/150

Iffland B, Brähler E, Neuner F, Häuser W, Glaesmer H. Frequency of child maltreatment in a representative sample of the German population. BMC Public Health 2013;13(1):980.

Public Health, Environmental and Occupational Health

2.321

45/347

Langhorst J, Hofstetter A, Wolfe F, Häuser W. Short-Term Stress, but Not Mucosal Healing Nor Depression Was Predictive for the Risk of Relapse in Patients with Ulcerative Colitis: A Prospective 12-Month Follow-up Study. Inflamm Bowel Dis 2013;19(11):2380-6.

Gastroenterology

 

 

5.475

9/74

Bernardy K, Klose P, Busch AJ, Choy EH, Häuser W. Cognitive behavioural

therapies for fibromyalgia. Cochrane Database Syst Rev 2013;9:CD009796.

Medicine, General & Internal

5.935

10/150

Glombiewski JA, Bernardy K, Häuser W. Efficacy of EMG- and EEG-Biofeedback in

Fibromyalgia Syndrome: A Meta-Analysis and a Systematic Review of Randomized

Controlled Trials. Evid Based Complement Alternat Med 2013;2013:962741.

Integrative & Complementary Medicine

2.175

4/24

Häuser W, Marschall U, L'hoest H, Komossa K, Henningsen P. [Administrative prevalence, treatment and costs of somatoform pain disorder : Analysis of data of the BARMER GEK for the years 2008-2010.]. Schmerz 2013; 27:380-6

Anesthesiology and Pain Medicine

1.504

22/29

Nüesch E, Häuser W, Bernardy K, Barth J, Jüni P. Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis 2013 ;72(6):955-62.

Rheumatology

9.270

1/28

Glaesmer H, Schulz A, Häuser W, Freyberger HJ, Brähler E, Grabe HJ. [The Childhood Trauma Screener (CTS) - Development and Validation of Cut-Off-Scores for Classificatory Diagnostics]. Psychiatr Prax. 2013;40(4):220-6.

SSCI

1.693

 

Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F, Langhorst J,

Weiss T, Thoma R, Winkelmann A, Häuser W. [Are members of fibromyalgia syndrome

self-help groups "different"? : Demographic and clinical characteristics of members and non-members of fibromyalgia syndrome self-help groups.]. Z Rheumatol 2013; 72:474–481

Rheumatology

0.456

26/28

Häuser W, Galek A, Erbslöh-Möller B, Köllner V, Kühn-Becker H, Langhorst J,

<span style="font-size: 10pt;

Presentations/ teachings
Qualifications

1989-1993

Research project on the psychophysiology of extreme endurance training (ultratriathlon) with the institute of sports medicine of the university Saarbrücken, Germany (Professor W. Kindermann)

1993-1994

Research project on extracorporal shock wave lithotripsy of gallballder stones with the Department of Gastroenterology, Sanjay Gandhi Post-Graduate Institute on medical sciences, Lucknow , India (Professor G. Choudhuri)

2000-2007

Speaker of the working group “quality of life” of the competence network “Chronic inflammatory bowel disease”, sponsored by the German Ministry of Education and Research and the German Crohn’s Disease/Ulcerative Colitis Association DCCV. Validation of German versions of disease-specific questionnaires on health-related quality of life in IBD

2004-2008

 

 

 

 

 

 

 

 

2004-2008

Research project “The German Celiac Health Survey” on behalf of the German Celiac Society together with the Department of Gastroenterology of the J.W. Goethe University Frankfurt, Germany (Professor W. Caspary). Development of a disease-specific questionnaire on health-related quality of life for celiac disease patients

 

Research projects on validations of German versions of disease-specific questionnaires on health-related quality of life in patients with chronic liver diseases with Prof. D. Grandt (Klinikum Saarbrücken, Germany) and Prof. F.Muthny (Department of Medical Psychology, University Münster)

 

2007-2008

Research project on the “Definition and classification of fibromyalgia” on behalf of the German Fibromyalgia Association DFV

2011-2012

 

 

2010 -

 

 

 

2010 -

 

 

 

 

 

2010 -

 

 

 

 

 

 

 

 

2018 -

 

 

 

 

2021-

Research project on the “German Fibromyalgia Consumer reports” on behalf of the German League of People Against Rheumatism

Research projects on fibromyalgia syndrome with Prof. F. Wolfe, National Databank of Rheumatic Diseases, USA

 

Research projects on the prevalence and predictors of chronic pain and of childhood abuse in the general German population with Prof. E. Brähler, Department of Medical Psychology, University Leipzig, Germany

 

Health care services research with Dr. Marschall, BARMER (one large German health statutory company) on administrative prevalence and health care costs of insured people with somatoform pain disorder, fibromyalgia and irritable bowel syndrome and with chronic non- cancer pain and use disorder of prescribed opioids and cannabis-based medicines

 

Research projects on cannabis use of patients with rheumatic diseases with Prof. MA Fitzcharles (Mc Gill University, Montreal, Canada)

 

Research projects on prescribed cannabis-based medicines use disorder with Prof. S. Gottschling (Department of Pain Medicine and Palliative Care, University Homburg/Saar, Germany), Dr. Silviu Brill (Tel-Aviv Sourasky Medical Center, Israel) and Prof. MA Fitzcharles, Mc Gill University, Montreal, Canada

 

Functions in scientific societies

2000 -

Speaker of the working group “Visceral Pain” of the German Association of the Study of Pain DGSS

2004- 2012

Vice President of the German Interdisciplinary Association of Pain Therapy DIVS

2006-2009

Member of the steering committee of the interdisciplinary guideline on “Opioids in non-cancer pain” of the German Association of the Study of Pain DGSS

2007- 2021

Participant of the guidelines on Crohn’s disease, diverticular disease, ulcerative colitis and irritable bowel syndrome of the German Society of Gastroenterology

2007-2021

Head of the steering committee of the interdisciplinary guideline on “Definition, diagnosis, pathophysiology and therapy of fibromyalgia syndrome” of the  German Association of the Study of Pain

2007 - 2019

Member of the medical advisory board of the German Celiac Association DZG

2007-

 

2021-

 

 2016-

 

 

2014-2021

Member of the medical advisory board of the German Fibromyalgia Association DFV

Member of the medical advisory board of the European network of Fibromyalgia Associations

Co-editor of the Pain Palliative and Supportive Care Group of the Cochrane Collaboration

 

Head of the steering committee of the interdisciplinary guideline on “Opioids in non-cancer pain” of the German Association of the Study of Pain DGSS

 

2018-2019

 

 

Head of the task force of the European Pain Federation of a position paper on medical cannabis and cannabis- based medicines for chronic pain

2019-2020

Head of the taks of the European Pain Federation of a position paper on opioids for chronic non-cancer pain

2021

Head of the working group medicine of the National Pandemic Cohort Network (NAPKON)

 

This website uses cookies to provide the best possible functionality.